Notably, METTL3 enhances the development of lung adenocarcinoma, likely through the promotion of tumour occurrence and the inhibition of cell iron death by upregulating SLC7A11 expression [54]. This evidence concerns the gene SLC7A11 and lung adenocarcinoma.